银杏达莫注射液治疗肺心病心力衰竭68例

Treatment of Pulmonary Heart Disease with Yinxingdamo Injection——Clinical Observation of 68 Cases

目的观察中西医结合治疗肺心病心衰的临床疗效。方法将130例老年肺心病患者随机分成2组,对照组62例,治疗组68例,治疗组在常规治疗同时加用银杏达莫注射液20 ml,1次/d,连用14 d。2组患者在治疗前后均测血液流变学和血气分析各项指标。结果治疗组治疗前后及与对照组治疗后比较,血液流变学各项指标明显改善,差别显著(P<0.05),血气分析中氧分压提高,二氧化碳分压降低(P值均<0.05)。结论银杏达莫注射液有增加红细胞变形能力,降低红细胞聚集能力和降低血粘度作用,还可提高氧分压和降低二氧化碳分压,定期应用可提高肺心病患者生活质量和存活率,有一定临床意义。

Objective To observe the combination of traditional Chinese medicine and western medicine treatment of pulmonary heart disease in clinical efficacy. Methods 130 cases of elderly patients with pulmonary heart disease were randomly divided into two groups, the control group of 62 cases, the treatment group of 68 cases. The treatment group was at the same time in the conventional therapy plus Yinxingdamo 20 mL injection, once a day, for 14 d. Patients in both groups before and after treatment were tested blood rheology and blood gas analysis of the indicators. Results According to the comparason of both groups before and after treatment, blood rheology of the indicators was improved significantly, the difference was significant （P 〈 0.05） , partial pressure of oxygen was increased in the blood gas analysis, carbon dioxide partial pressure was decreased （P 〈 0.05）. Conclusion Yinxingdamo injection increases red blood cell deformability and lowers red cell aggregation, and reducing blood viscosity can inrease and decrease oxygen partial pressure of carbon dioxide, regular application of pulmonary can improve quality of life and survival mentioned, and has certain clinical significance.